134 related articles for article (PubMed ID: 34848025)
1. MRI characteristics for differentiating mucinous borderline ovarian tumours from mucinous ovarian cancers.
Yang XY; Li X; Ma FH; Li HM; Zhao SH; Li YA; Qiang JW
Clin Radiol; 2022 Feb; 77(2):142-147. PubMed ID: 34848025
[TBL] [Abstract][Full Text] [Related]
2. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
4. Can MRI features differentiate ovarian mucinous carcinoma from mucinous borderline tumor?
Kaga T; Kato H; Hatano Y; Kawaguchi M; Furui T; Morishige KI; Matsuo M
Eur J Radiol; 2020 Nov; 132():109281. PubMed ID: 32961452
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
[TBL] [Abstract][Full Text] [Related]
6. MRI can be used to differentiate between primary fallopian tube carcinoma and epithelial ovarian cancer.
Yang Y; Xiao Z; Liu Z; Lv F
Clin Radiol; 2020 Jun; 75(6):457-465. PubMed ID: 32160944
[TBL] [Abstract][Full Text] [Related]
7. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
[TBL] [Abstract][Full Text] [Related]
8. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.
Zhang X; Li M; Tang Z; Li X; Song T
Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252
[TBL] [Abstract][Full Text] [Related]
10. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
[TBL] [Abstract][Full Text] [Related]
11. MRI for discriminating metastatic ovarian tumors from primary epithelial ovarian cancers.
Xu Y; Yang J; Zhang Z; Zhang G
J Ovarian Res; 2015 Aug; 8():61. PubMed ID: 26310488
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level.
Zhang G; Yao W; Sun T; Liu X; Zhang P; Jin J; Bai Y; Hua K; Zhang H
J Ovarian Res; 2019 Jun; 12(1):59. PubMed ID: 31242916
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
14. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
15. Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values.
Wang T; Li W; Wu X; Yin B; Chu C; Ding M; Cui Y
PLoS One; 2016; 11(2):e0149318. PubMed ID: 26894926
[TBL] [Abstract][Full Text] [Related]
16. Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors.
Hasbay E; Görgülü G; Sanci M; Özamrak BG
Rev Assoc Med Bras (1992); 2023; 69(7):e20230110. PubMed ID: 37466596
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
18. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
19. MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
Ma FH; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
J Magn Reson Imaging; 2014 Sep; 40(3):745-51. PubMed ID: 24395397
[TBL] [Abstract][Full Text] [Related]
20. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]